by Morton Walker, DPM.
Widely used in Japan as an adjunctive treatment for cancer - reprinted with permission from Townsend Letter for Doctors & Patients, October 1998, issue #183
Did you know that numbers of different fungi have, for at least 40 centuries, been vital parts of mythology and medical practice around the world?
Fungally-derived phytochemicals find significance among peoples along the Pacific Rim (e.g. Japan and Thailand), on the Asian continent (i.e. China and Russia), plus inside darkest Africa (especially for the Yoruba tribe of southwestern Nigeria).
Among the more than half-a-million varieties of fungi (with over 100,000 named species), mushrooms hold value especially for Europeans, who have always appreciated the gastronomic excellence of both the domestic- and wild-growing species.
Back
To Top
Gourmet cooks, especially French, Belgian, and Austrian chefs, consider mushrooms “flowers of the fall” and label them in their recipes with this loving appellation.
Are you aware that mushrooms are the perfect food for staying trim, remaining healthy, and feeling a sense of wellbeing?
Because mushrooms contain only insignificant amounts of fat - predominantly as unsaturated linoleic acid - eating them may help one to hold onto a healthy cardiovascular system and stay free of malignancy.
Are you aware that most inhabitants of the United States, Canada, Great Britain, Australia, and New Zealand are rather ignorant about mushrooms?
In fact, these English-speaking populations actually dislike or fear ingesting mushrooms, because of “fungophobia” - the view that they are associated with unsavory or “poisonous” fungi.
Back
To Top
Do you have fungophobia? In contrast to your possible prejudice or general misinformation, be advised that mushrooms possess medicinal value far surpassing or at least on a par with such beneficial phytochemicals (nutraceuticals) as oligomeric proanthocyanidines (OPCs), d-alpha tocopherol (natural vitamin E), thymus gland extract, CoEnzyme Q10, olive leaf extract, and particular probiotics.
Did you know that certain mushrooms are extremely safe to consume and definitely provide the user with high quality healing nutrients for a variety of serious health problems?
Listed in the latter category are those mushrooms belonging to the family of Polyporaceae (also known as Basidiomycotinae).
Among these Polyporacea species is Coriolus versicolor which shows great biological activity for the treatment of immune dysfunction.
Back
To Top
Medicinal Mushroom User Steven Bailey, ND
“Of all medicinal plants, Coriolus versicolor is one of the safest and most effective agents any doctor can use against chronic diseases.
This mushroom places no metabolic demand on the liver or extenuating stress on the kidneys,” says Portland, Oregon naturopathic doctor Steven Bailey, ND. “So when one looks at treatment risks for all of the recognized phytochemical products, the Coriolus versicolor mushroom exhibits one of the lowest treatment imperilments for viral infection, malignant tumors, or immune system depression.
“I see Coriolus versicolor as having a very high degree of reliability for boosting human and animal immune system function.
It does this in ways that are beneficial not only for the body’s surveillance or destruction of tumors but also as a protector against secondary infection,” Dr. Bailey confirms. “The two immunologically active fractions of this therapeutic mushroom negate or decrease side effects connected with chemotherapy, surgery, and radiotherapy.
Back
To Top
And those fractions offset other chronic immune imbalances, including autoimmune diseases. Definitely I consider Coriolus versicolor to be a potent immune system builder that’s easy for the patients to ingest as capsules.”
In private practice for 15 years, Dr. Bailey has taught courses in nutrition and pharmacognosy at the National College of Naturopathic Medicine in Portland. He has been using the Coriolus versicolor polysaccharide extract for three years to relieve such illnesses as hepatitis B and C, AIDS, herpes genitalis, cancer, general immune suppression, and post-surgical recovery. Usually Dr. Bailey doesn’t administer the Coriolus polysaccharides as a single treatment agent; rather, it becomes part of his fairly comprehensive nutritional protocol.
“Of course, some cancer patients take Coriolus versicolor even while they engage in radiation treatment or chemotherapy” Dr. Bailey advises. “Or, the patients don’t submit to chemotherapy or radiotherapy at all but rely, instead, exclusively on nutritional therapies with the mushroom as a main treatment ingredient.
Back
To Top
For example, one of my patients, a 34 year-old woman working in the health field consulted me with a cancer spreading at two sites in her lungs. Orthodox treatment had been tried but no longer was effective. She embarked on nutritional therapies and completed six months of taking Coriolus versicolor.
Radiological examination then showed that all of her lung tumors had disappeared. Seeing her current progress, orthodox medicine probably would declare this patient to be cured.”
Physical Characteristics of Coriolus versicolor
Published in Japan since the 1970s, over 400 clinical studies have shown that a purified extract derived from the mushroom, Coriolus versicolor, offers strong benefits for the immune system.
The extract is a protein-bound polysaccharide preparation isolated from the mushroom’s mycelia and fruit bodies by use of hot water in a multi-step procedure. After completion of the extraction process, the evolved solution is concentrated and dehydrated.
The brownish mushroom powder remaining is encapsulated for easy ingestion. Taken either alone or with conventional chemotherapy or radiotherapy for cancer, three or more grams per day of this brown-powdered extract, administered orally, results in antitumor activity.
In vivo studies of rats and mice show that Coriolus polysaccharides work well against a variety of experimental animal cancers such as sarcoma, hepatoma, and fibrosarcoma.
Coriolus versicolor goes by a number of botanical names, including Trametes versicolor, Boletus versicolor, Polyporus versicolor, Polystictus versicolor, and the common idiomatic attribution of “turkey tail.”
The fruiting bodies do resemble a turkey tail in full plumage and the versicolor name comes from this mushroom being variously colored. In Japan it’s called “kawaratake,” which means mushroom by the river bank. Among the common people in China, the fungus is referred to as “yun-zhi,” indicating that it’s a cloud fungus and grows best in the rain.
Back
To Top
As an often seen denizen of the woods populating the temperate zones of North America, Asia, and Europe, Coriolus versicolor possesses fan-shaped fruiting bodies which grow in overlapping clusters on dead trees.
The mushroom’s top portion is zoned, usually in shades of brown, white, grey, or blue, and it sports hairy bands. The underside of its cap is white and shows minute pores which do not discolor after scratching.
The Active Medicinal Components
The mushroom’s active medicinal components-biological response modifiers which are protein-bound polysaccharides can be found in both the fungus’ fruiting body and its mycelium (the vegetative stage).
Although these concentrated polysaccharide extracts are sold under a variety of trade names in North America and Asia, they are most commonly referred to by the Japanese language designated, water-soluble “Polysaccharide Kureha” or Polysaccharide K (commonly referred to as PSK by those informed patients using Coriolus versicolor). PSK contains the main components of -1,4- and -1,6- glucans with -1,3- and 1,6- linkages. Also the mushroom contains other medicinal components of secondary importance.
Back
To Top
All of these potent but safely used medicinal components are reported as effective against stomach (gastric) cancer, uterine cancer, colon cancer, and lung cancer.
As clinically and anecdotally reported below, the mushroom extract additionally works well against colorectal cancer, prostate cancer, breast cancer, and liver cancer.
PSK Acts Alone Against Colorectal Cancer
Publishing in Cancer Immunology and Immunotherapy, no less than 11 oncological researchers representing six prestigious medical schools in Japan conducted a randomized double-blind trial on 111 patients who had colorectal cancer.
After they had undergone surgical operations for their cancers, 56 patients were given PSK alone as an active treatment substance, and 55 other post surgical patients merely received a placebo.
Comparing the two groups, these eleven medical researchers advised, “There is significant prolongation of disease-free periods for patients with colorectal cancer who took PSK.
Additionally. polymorphonuclear leukocytes from patients treated with Coriolus versicolor showed remarkable enhancement in their activities, such as random and/or chemotactic locomotion, and phagocytosis.
In conclusion, PSK was useful as a maintenance therapy for patients after their curative surgical operations for colorectal cancer. The beneficial effects were probably due to the activation of leukocyte functions as one of the many biological-response-modifying activities induced by PSK.
Back
To Top
Kenneth Bock, MD Observes PSK Boosts NK Cells
“Because it increases natural killer [NK] cell activity, I think of using Coriolus versicolor mainly when I’m confronted with a patient suffering from cancer or a viral infection,” says Kenneth A. Bock, MD, medical director of two wholistic medical clinics, one located in Rhinebeck, New York and the other in Albany, New York. “This mushroom is one of the main medicinal compounds I use to boost a diminished blood reading which records NK activity. PSK does produce a marked improvement in NK cell function and number, something I monitor by testing. If the blood reading is low, my patient takes greater amounts of PSK capsules. And, although it’s an expensive and sophisticated assay, I repeat my NK cell testing inside of a month or two. In a number of patients, I’ve seen some nice blood test improvements.
“Before consulting me, a few patients with advanced metastatic cancer show NK cell activities of only 2 or 3 minute units (m/u). Normal measurements for the laboratory I employ is between 20 and 50 m/u. By using PSK for most of these patients, I have observed their NK cells increasing into the normal range. They then experience an improved prognosis,” says Dr. Bock. “I can illustrate what I’m saying by providing a before-and-after patient case history plus the literature that backs my claim.
Back
To Top
“Here is a white, married male with the initials M.E., 60 years old, working as a computer consultant, who originally had been followed medically for hypertension, hyperlipidemia, and arteriosclerosis, during 1995. He also exhibited laryngeal polyps which were cancerous. M.E. received radiation therapy as a followup to the surgery performed to remove these polyps,” points out Dr. Bock. “At the time of surgery, a CT scan to his pelvis was negative for cancer metastasis to the prostate. But later, in April 1997, M.E. did show an elevated PSA [prostate-specific antigen] and underwent an additional medical workup, including biopsy. Workup results indicated his true diagnosis, which was prostate cancer. His blood test showed diminished natural killer cell activity at the level of 6 m/u. Still, M.E. wanted no conventional therapy for the prostate cancer,” Dr. Bock tells me. “So I started him on alternative medical therapies for prostate cancer and to improve his deficient NK cell activity. Coriolus versicolor was a definite part of M.E.’s treatment regimen. “Within two months, the patient’s NK cell activity elevated to 18 m/u. And two months after that his NK cell activity increased to a normal 31 m/u. Now M.E. is doing well physically, and he tells me he feels great! I would say that this type of response to PSK therapy is usual; the patient’s quality of life does improve dramatically and he or she feels a sense of wellbeing,” Dr. Bock states.
Kenneth A. Bock, MD, lectures extensively to health professionals and consumer groups on wholistic medicine. Engaged in family practice, Dr. Bock specializes in treating patients for allergies; plus, he treats heart and blood vessel diseases for which he employs chelation therapy, nutritional therapies, and preventive medicine.
Back
To Top
Animal Studies of Coriolus versicolor
Animal studies investigating the efficacy of Coriolus versicolor indicate it has marked immune system-enhancing activity and a broad antineoplastic scope. It prolongs the survival time of irradiated (cancer-induced) mice by stimulating phagocytic activity of macrophages and improving the functions of the reticuloendothelial system. For another rodent-type of disease, cyclophosphamide-induced granulocytopenia in mice, PSK caused a significant increase in granulocyte production. Also it restored antibody (IgG) production in mice bearing sarcoma 180, but not in normal mice.
PSK acts directly against tumor cells as well as indirectly in the host to boost cellular immunity. The following is a listing of cancers for which it is known to be efficacious in animals: adenosarcoma, fibrosarcoma, mastocytoma, plasmacytoma, melanoma, sarcoma, carcinoma, mammary cancer, colon cancer, and lung cancer. Indeed, injection of the PSK compound at one tumor site shows tumor growth inhibition at other sites, thus helping to prevent metastasis. Moreover, its antitumor activity increases when PSK is administered in combination with radiation, chemotherapy, or immunotherapy. Giving the polysaccharide substance in 10% or less of rat feeds does suppress carcinogen-induced rodent cancers of the colon, esophagus, breast, and lung.
PSK demonstrates antiviral activity and may be effective against the human immunodeficiency virus (HIV) infection by modifying the viral receptor or by stopping it from binding with lymphocytes. Another mechanism through which PSK shows general antiviral activity is through the stimulation of interferon production.
Back
To Top
Whole Coriolus versicolor lowers serum cholesterol in animals. In combination with the herb Astragalus membranaceus Bunge, it enhances neutrophil function and speeds recovery in rabbits suffering from burns. A powdered extract of PSK from the 70% ethanolic tincture of this species tested in rats by injection in a Hippocratic screening of higher fungi did demonstrate mild tranquilizing and diuretic effects.
PSK is Supportive of Chemotherapy/Radiotherapy
Providing strong benefits for the immune system when given alone, Coriolus versicolor works even more supportively against cancer after it's applied with chemotherapy and/or radiotherapy. In fact, out of 200 adjunctive phytochemicals screened for antitumor activity by Japanese researchers in 1971, PSK was selected as the best adjunctive treatment.
The researchers suggested that this medicinal mushroom seemed to protect the immune system’s activity from being suppressed by the chemotherapy drugs and by the toxic processes of the cancer itself. Added to that finding, a ten year study of 185 patients with lung cancer showed that combining PSK with radiation therapy produced “satisfactory” tumor shrinkage and better survival rates for patients with stage I cancer (39%) and stage II cancer (22%) compared against those patients with stage I cancer (16%) and stage II cancer (5%) who did not receive this combination of therapies.
Reporting the above study in another more exacting way: From 1976 to 1985, 185 patients with non-small cell lung cancer at stages I, II, and III were treated with definitive radiotherapy in Gunma University Hospital at the Gunma University School of Medicine in Maebashi, Japan. The long term survivors were analyzed carefully. Those who had received Coriolus versicolor as adjuvant treatment showed more satisfactory tumor shrinkage and their five year survival rate was better than those patients not receiving PSK. That is, PSK patients with stages I or II disease showed up with 39% survival; PSK patients with stage III cancer had 22% survival. Comparing these survivors with the stage I and stage II non-PSK group, we see that these non-PSK patients had only 16% and 5% survival, respectively. The non-PSK stage III patients had no survivors.
In Japan, the standard adjuvant treatment after resection of gastric cancer is a combination of two cytotoxic drugs, intravenous mitomycin plus oral fluorouracil. As a clinical test, the protein-bound polysaccharide PSK was added to this standard chemotherapy for 262 randomly assigned patients. Half received Coriolus versicolor and half took the usual chemotherapy alone after all of them had undergone what the Japanese label as “curative” gastrectomy. During a minimum followup of five years (ranging from five to seven years), the clinical testing took place at 46 institutions in central Japan.
Back
To Top
PSK improved the cancer patients’ five-year, disease-free rate at 70.7% versus 59.4% in a standard treatment group (p=0.047). And it improved their five-year survival rate at 73.0% versus 60.0%, (p=0.044) as well. The two regimens had only slight toxic effects, consisting of nausea, leucopenia, and liver function impairment. There were no significant differences between the groups. The treatments were clinically well tolerated and compliance of patients was good. In their paper published in Lancet, the researchers concluded, “Addition of PSK to adjuvant chemotherapy with mitomycin and fluorouracil is beneficial as treatment after curative gastrectomy.”
Between January 1980 and December 1990, 227 operable breast cancer patients with vascular invasion in their tumors and/or in their metastatic lymph nodes were randomized into three treatment groups. Group one received a combination of toxic therapies, what the researchers labeled as “FEMP” (5-fluorouracil, cyclophosphamid, mitomycin C, and predonisone). Group two received FEMP plus LMS (levamisole). Group three received FEMP plus PSK.
The seven Japanese researchers concluded: “Immunochemotherapy using PSK improved the prognosis of patients having operable breast cancer with vascular invasion..The prognosis of the FEMP + PSK group tended to be better than that of the FEMP group. FEMP + PSK is better because of its usefulness including good compliance.
Twenty-eight patients suffering from acute leukemia who had achieved complete remission participated in a clinical trial. Starting in September 1976, half of these patients entering the chemo-PSK immunotherapy group received the medicinal mushroom, Coriolus versicolor, and half entering the strictly chemotherapy group did not. To retain the patients’ remission, all of them received three courses of the chemotherapy combination of cytoxics consisting of 40 units/kg/day of neocarzinostatin; 0.8 -1.6 mg/kg/day of cytosine arabinoside; 0.6 - 0.8 mg/ kg/day of daunorubicin; and 0.8 -1.6 mg/kg/day of prednisolone on days one to four for acute non-lymphocytic leukemia, and 0.04 mg/kg/day of vincristine on day one: 0.6 - 0.8 mg/kg/day of daunorubicin; and 0.8 - 1.6 mg/kg/day of prednisoline on days one to four for acute Iymphocytic leukemia.
Back
To Top
The durations of complete remission and survival in the chemo-PSK immunotherapy group (receiving PSK) showed significant prolongation compared to that of the Strictly chemotherapy group (not receiving PSK). The median duration of complete remission for this PSK group was thirty-six weeks and that for the non-PSK group was twenty-five weeks. The average survival time from diagnosis of the PSK group was twenty-one months and that of the non-PSK group was twelve months.
Tori Hudson, ND, Uses Coriolus versicolor
“The only condition I’ve been using Coriolus versicolor for is breast cancer, stage II and above, in which the patients have been actively receiving chemotherapy. If they are just starting their chemotherapy, I’ve added PSK. When the patients are finished with their chemotherapy I’ve continued the PSK. This procedure is followed in accordance with my understanding of the few research articles I’ve read relative to breast cancer patients and PSK. My intention is to keep the breast cancer patient taking Coriolus versicolor for a total of five years. But I’ve been using the mushroom for only a year now,” says naturopathic physician Tori Hudson, ND.
Dr. Tori Hudson, whom all of us recognize as a columnist for the Townsend Letter for Doctors & Patients, is a professor teaching at the National College of Naturopathic Medicine in Portland. She is health care director at her Portland, Oregon clinic which operates under the name: “A Woman’s Time.” “I have just begun using PSK for a man who is facing the recurrence of gastric cancer. He’s had a full gamut of therapies and still shows elevated cancer markers which his oncologist finds untreatable. The patient was referred to me for some alternative cancer therapy because conventional oncology has nothing more to use on him,” says Dr. Hudson. “My impression is that patients taking Coriolus versicolor are experiencing less side effects from chemotherapy such as diminished fatigue, less nausea, (but not less hair loss), and more stable white blood cell counts. I have not measured the natural killer cell counts.”
Back
To Top
A Patient’s Experience with Liver Cancer Reduction
A 64 year-old electrical engineer in Tyler, Texas. Allen Greenstaff had been doctoring with liver cancer for six years. In the beginning stages of his malignancy, he took chemotherapy which eventually proved to do no good. And the oncologist offered him absolutely nothing more as treatment, not even personal care to accomplish a better quality of life for himself - no improved diet, nutrients, exercise, meditation - just nothing at all.
“That doctor was the most negative man I ever met,” said Mr. Greenstaff. “After the chemo failed, he threw up his hands, shrugged his shoulders, wished me good luck, and said there was nothing else he could do. And surgery couldn’t be performed either, because the consulting surgeon saw that the tumor was wrapped around my vena cava blood vessel.”
The patient replied to his oncologist, “I totally reject what you are telling me. I do not accept that nothing can be done to affect the outcome of this disease.” When the doctor said, “Well, I know what I’m talking about when it comes to cancer. I’m a scientist,” Allen Greenstaff shot back, “Yes, but you’re not God!”
Even with being abandoned by his oncologist, today the patient is healthy once again after utilizing alternative methods of healing, most especially by his self-administration of oral Coriolus versicolor. Mr. Greenstaff’s tumor, which had been situated on the left lobe of the liver, was sized at 10 cm by 7 cm and by the longitudinal measurement of 9 cm. Now, after he has been taking capsules of PSK, the tumor has shrunk to 6 cm by 4 cm by 3 cm (longitudinally). The patient had learned about Coriolus versicolor from his contacting Medline on the internet. By digging into the world wide web, he has saved himself. Remarkably, the volume of Mr. Greenstaff’s liver cancer has reduced to less than 10% of its original size, from 630 cm down to 60 cm. And his carcinoembryonic antigen (CEA) cancer marker has improved dramatically as well, dropping from 296 to 97.9.
Today, after two years, Mr. Greenstaff still swallows those usual, brownish colored mushroom capsules, which he intends to take the rest of his life. He is well-versed in the efficacy of Coriolus versicolor, since the man has read nearly 400 studies about PSK that he printed out from the internet.
Back
To Top
CORIOLUS VERSICOLOR STANDARDIZED EXTRACT (PSK) has recently been trademarked in the U.S. as VPS and is manufactured by JHS Natural Products.
With a suggested retail price of $149.95 - $169.95, It is now available at the Discounted Price of $. per bottle (a one month supply at suggested dosages) or . To order with a credit card, Call WILDFIRE CONSULTING Toll-Free at: 1-888-583-3532
Back
To Top
References:
1. Ohno, R.; Imai, K.;Yokomaku, S.; and Yamada, K. Antitumor effect of protein-bound polysaccharide preparation, PS-K, against the 3 methylcholanthrene-induced fibrosarcoma in C57BL/6 mice. Gann (Japan) 66:679-681, 1975.
2. Arora, D. All That The Rain Promises and More. (Berkeley, California: Ten Speed Press, 1991).
3. Gilbertson, R.L. and Ryvarden, L. North American Polypores. (0slo, Norway: Fungiflora, 1986).
4. Arora, D. Mushrooms Demystified. (Berkeley, California: Ten Speed Press, 1986).
5. Namba, TK. Genshoku Wakanyaku Zukan. (Osaka, Japan: Hoikusha, 1980), p. 247.
6. Yang, Q.Y., et al. A new biological response modifier - PSP. From Mushroom Biology and Mushroom Products. S.-. Chang et al (eds.). (Hong Kong: The Chinese University Press, 1993), pp. 247-259.
7. Hobbs, C. Medicinal Mushrooms: An Exploration of Tradition, Healing, & Culture, Third Edition. (Loveland, Colorado: Interweave Press, Inc., December 1996), p. 161.
8. Sakagami, H. and Takeda, M. Diverse biological activity of PSK (Krestin), a protein bound polysaccharide from Coriolus versicolor. Proceedings of the Pirst International Conference on Mushroom Biology and Mushroom Products. August 23-26, 1993, The Chinese University of Hong Kong, Hong Kong.
9. Mushroom Biology and Mushroom Products. Chang, S.-T. et al. (eds.) (Shatin, Hong Kong: Chinese University Press, 1993), pp. 237-245.
10. Op. cit. Yang, Q.Y., et al., 1993.
11. Itoh,I.;Sakai,T.;Mori,T. Aspects of immunological antitumor agent and its clinical use PSK. Japanese Journal of Cancer Chemotherapy. 6:681, 1994.
12. Kumashiro, R.; Hiramoto, Y.; Okamura, T.; Kano, T.; Sano, C.C.; Inokuchi, K. Postoperative long-term immunostimulatory protein bound polysaccharide Kureha (PSK) therapy for advanced gastric cancer. In: Torisu, M.; Yoshida, T. (eds.) Basic Mechanisms and Clinical Treatment of tumor Metastasis. (New York City: Academic Press, 1985), p. 523.
13. Mitomi, T. and Ogoshi, K. Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer. Japanese Journal of Cancer Chemotherapy. 13:2532, 1992.
14. Nakazato, H.; Ichihashi, H.; Kondo, T. Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin for patients with curatively resected gastric cancer. Japanese Journal of Cancer Chemotherapy. 13:308, 1993.
15. Nimoto, M.; Toge, T.; Nakano, A.; Yanagawa, E.; Oride, M.; Hirano, M.; Nakanishi, K; Nosou, Y.; Yamada, Y.; Hattori, T. Adjuvant immunochemotherapy in patients with gastric cancer. Japanese Journal of Gastroenterol Surgery. 14:704, 1990.
16. Shiraki, S.; Mori, H.; Ito, A.; Kadomoto, N.; Yumagiwa, S.; Yumada, Y.;Noda,K. Adjuvant immunotherapy for carcinoma of uterine cervix with PSK. Japanese Journal of Cancer Chemotherapy. 9: 1031,1994.
17. Ikeda, T.; Sakai, T.; Saito, T.; Kosaki, G. Evaluation of postoperative immunochemotherapy for lung cancer patients. Japanese Journal of Cancer Chemotherapy 13:1044, 1991.
18. Torisu, M.; Hayashi, Y.; Ishimitsu, T.; Fujimura, T.; Iwasaki, K; Katano, M.; Yamamoto, H.; Kimura, Y.; Takesue, M.; Kondo, M.; Nomoto, K. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunology & Immunotherapy. 31:261-268, 1990.
19. Itoro, S. Enhancement of antitumor cell toxicity for hepatic lymphocytes by oral administration of PSK. International Journal of Immunopharmacology. 16(2):123-130,1994.
20. Etoe, K. Activation of human natural killer cells by the protein bound polysaccharide PSK independently of interferon and interleukin II. Immunology Letters. 31:241-246, 1992.
21. Ebihara, M. Peptide effect of biological response modifiers on murine cytomegalovirus infection. Journal of Virology. 61(1):117-122, July 1984.
22. Zhu, D. Recent advances on the active components in Chinese medicines. Abstracts of Chinese Medicines. 1:251-286, 1987.
23. Mayer, P. and Drews, J. The effect of a protein-bound polysaccharide from Coriolus versicolor on immunological parameters and experimental infections in mice. Infection. 8:13-21, 1980.
24. Nomoto, K. et al. Restoration of antibody-forming capacities by PSK in tumor-bearing mice. Gann. 66:365-374, 1975.
25. Tsukagoshi, S. et al. Krestin (PSK). Cancer Treatment Reviews. 11:131-155, 1984.
26. Ebina, T. Antitumor effect of PSK. (2) Effector mechanism of antimetastatic effect in the ‘double grafted tumor system’. Gon to Kagaku Ryoho. 14:1847-1853, 1987.
27. Op. cit. Tsukagoshi, S., 1984.
28. Tochikura, T.S. et al. A biological response modifier, PSK inhibits human immunodeficiency virus infection in vitro. Biochemistry, Biophysics Research Communications. 148:726-733, 1987.
29. Ebina, T. et al. Antitumor effect of PSK (1) Interferon inducing activity and intratumoral administration. Gon to Kagaku Ryoho. 14:1847-1863, 1987.
30. Yagashita, K. et al. Effects of Grifola frondosa, Coriolus versicolor, and Lentinus edodes on cholesterol metabolism in rats. Nihon Daigaku No-Juigakubo Gakujutsu Kenkyu Hokoku. 34:1-13, 1977.
31. Liu, B. et al. A new species of the genus Cordyceps. J. Wuhan Bot. Research. 3:23-24. From Abstracts of Chinese Medicines. 1:248,1985.
32. Malone, M.H. et al. Hippocratic screening of sixty-six species of higher fungi. Lloydia 30:250-257, 1967.
33. Anticancer botanicals that work supportively with chemotherapy. Alternative Medicine Digest. 19:84, Aug/Sept. 1997.
34. Yakawa, K; Mitsuhashi, N.; Saito, Y.; Takahushi, M.; Katano, S.; Shiojima, K.; Furuta, M.; Niibe, H. Effect of Krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer. Anticancer Research 3:1815-1820, 1993.
35. Nakazato, H.; Koike, A.; Saji, S.; Ogawa, N.; Sakamoto, J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet. 343: 1122-1126, 1994.
36. Iino, Y.; Yokoe, T.; Maemuru, M.; Horiguchi, J.; Takei, H.; Ohwada, S.; Morishita, Y. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. Anticancer Research. 15:2907-2912, 1995.
37. Nagao, T.; Komatsuda, M.; Yamauchi, K; Nozaki, H.; Watanabe, K.; Arimori, S. Chemoimmunotherapy with Krestin in acute leukemia. Tokai Journal of Experimental Clinical Medicine . 6(2):141-146, 1981.
IMPORTANT NOTICE: The information provided above has not been evaluated by the FDA, is for educational purposes only and is not intended to replace proper medical care, diagnose or prescribe. The use of Coriolus versicolor extract is meant to be used as nutritional support, not for the treatment of any disease. Your medical condition should be discussed with your physician before using this product.
Back
To Top
Buy
Coriolus Versicolor or PSK
Below:
2CheckOut.com Inc. (Ohio, USA) is an authorized retailer for
goods and services provided by Women's Health-Natural Solutions.com.
Check Out
Return to articles list